Latest On Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-07-18 06:01 EST | Dividend | A dividend of $0.66 has been announced on Mar 30, 2023. It will be paid Aug 28, 2023 with an ex-dividend date of Jul 18, 2023. | Neutral |  |
| 2022-07-18 06:01 EST | Dividend | A dividend of $0.49 has been announced on Mar 30, 2022. It will be paid Aug 29, 2022 with an ex-dividend date of Jul 18, 2022. | Neutral | |
| 2021-07-16 06:03 EST | Dividend | A dividend of $0.58 has been announced on Mar 26, 2021. It will be paid Aug 27, 2021 with an ex-dividend date of Jul 16, 2021. | Neutral | |
| 2020-11-26 23:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-03 09:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-02 09:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-29 06:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-17 06:00 EST | Dividend | A dividend of $0.48 has been announced on Mar 27, 2020. It will be paid Aug 21, 2020 with an ex-dividend date of Jul 17, 2020. | Neutral | |
| 2020-07-09 11:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 22:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 22:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-29 02:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 22:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 06:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 00:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 01:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 01:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 01:47 EST | Financials | Company financials have been released. | Neutral | |
About Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF):
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through Production, Distribution, Retail, and Others segments. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestion and immune system, cardiovascular, anti-infection, nervous system and mental disorder, and oncology. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug retail business; and provision of consulting services, as well as in the assets management operations, etc. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 16 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
General
- Name Shanghai Pharmaceuticals Holding Co., Ltd
- Symbol SHPMF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Distribution
- Full Time Employees 47,778
- Fiscal Year EndDecember
- Web URLhttp://www.sphchina.com
View More
Valuation
- Trailing PE 7.51
- Forward PE 5.88
- Price/Sales (Trailing 12 Mt.) 0.17
- Price/Book (Most Recent Quarter) 0.73
- Enterprise Value Revenue 0.05
- Enterprise Value EBITDA 1.15
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin 2%
- Return on Assets 3%
- Return on Equity 10%
- Revenue Per Share $0
- Gross Profit 26.52 billion
- Quarterly Earnings Growth 10.6%
View More
ESG Rating
Highlights
- Market Capitalization 7.54 billion
- PEG Ratio 0.9
View More
Share Statistics
- Shares Outstanding 919.07 million
- Shares Float 1.52 billion
- % Held by Insiders 1203%
- % Held by Institutions 48.15%
View More
Technicals
- Beta 0.2
- 52 Week High $1.99
- 52 Week Low $1.08
- 50 Day Moving Average 1.72
- 200 Day Moving Average 1.73
View More
Dividends
- Forward Annual Dividend Rate $0.06
- Forward Annual Dividend Yield 3.45%
- Payout Ratio 33%
- Dividend Date 2017-08-21
- ExDividend Date 2020-07-17
- Dividend Per Share $0.06
- Dividend Yield 0%
View More
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Dividend Calendar:
SHPMF's last dividend payment was made to shareholders on August 21, 2017.
Shanghai Pharmaceuticals Holding Co., Ltd pays out 33% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-09-30 | $53.16 billion | $0.06 | ||
| 2020-06-30 | 2020-09-30 | $46.72 billion | $0.06 | ||
| 2020-03-31 | 2020-06-30 | $N/A | $0.07 | ||
| 2019-12-31 | 2020-03-31 | $45.95 billion | $0.05 | ||
| 2019-09-30 | 2019-12-31 | $48.04 billion | $0.03 | ||
| 2019-06-30 | 2019-09-30 | $46.57 billion | $0.05 | ||
| 2019-03-31 | 2019-06-30 | $46.01 billion | $0.06 | ||
| 2018-12-31 | 2019-03-31 | $41.48 billion | $0.06 | ||
| 2018-09-30 | 2018-12-31 | $41.72 billion | $0.03 | ||
| 2018-06-30 | 2018-09-30 | $39.49 billion | $0.07 | ||
| 2018-03-31 | 2018-06-30 | $36.39 billion | $0.05 | ||
| 2017-12-31 | 2018-03-31 | $31.82 billion | $0.06 | ||
| 2017-09-30 | 2017-12-31 | $26.58 billion | $0.05 | ||
| 2017-06-30 | 2017-09-30 | $32.65 billion | $0.04 | ||
| 2017-03-31 | 2017-06-30 | $33.13 billion | $0.05 | ||
| 2016-12-31 | 2017-03-31 | $30.25 billion | $0.05 | ||
| 2016-09-30 | 2016-12-31 | $0.04 | |||
| 2016-06-30 | 2016-09-30 | $0.04 | |||
| 2016-03-31 | 2016-06-30 | $0.05 | |||
| 2015-12-31 | 2016-03-31 | $0.05 | |||
| 2015-09-30 | 2015-12-31 | $0.04 | |||
| 2015-06-30 | 2015-09-30 | $0.04 | |||
| 2015-03-31 | 2015-06-30 | $0.05 | |||
| 2014-12-31 | 2015-03-31 | $0.04 | |||
| 2014-09-30 | 2014-12-31 | $0.04 | |||
| 2014-06-30 | 2014-09-30 | $0.04 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.04 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.04 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.03 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.03 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.03 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.04 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.03 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.02 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.03 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.04 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.02 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.02 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.03 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.07 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.02 | $0.00 |
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | 363.38 million | 335.48 million | N/A | 489.7 million | 295.66 million |
| Income Before Tax | 1.87 billion | 2.04 billion | N/A | 1.26 billion | 1.56 billion |
| Selling General Administrative | 4.48 billion | 4.29 billion | N/A | 4.43 billion | 4.32 billion |
| Gross Profit | 7.06 billion | 6.86 billion | N/A | 7.14 billion | 6.39 billion |
| Ebit | 2.24 billion | 2.45 billion | N/A | 2.98 billion | 1.48 billion |
| Operating Income | 2.12 billion | 2.22 billion | N/A | 2.98 billion | 1.48 billion |
| Income Tax Expense | N/A | 383.81 million | 338.9 million | 471.3 million | 269.06 million |
| Total Revenue | 53.16 billion | 46.72 billion | N/A | 45.95 billion | 48.04 billion |
| Cost of Revenue | 46.1 billion | 39.86 billion | N/A | 38.81 billion | 41.65 billion |
| Total Other Income Expense Net | N/A | N/A | N/A | -1.73 billion | 80.49 million |
| Net Income From Continuing Operations | 1.48 billion | 1.65 billion | N/A | 786.32 million | 1.29 billion |
| Net Income Applicable to Common Shares | N/A | 1.4 billion | 1.04 billion | 682.02 million | 1.11 billion |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -221.91 million | -1.36 billion | 692.96 million | 13.55 million | 31.43 million |
| Change to Liabilities | N/A | -1.55 billion | N/A | 2.45 billion | -3.13 billion |
| Total Cash Flow from Investing Activities | N/A | -1.36 billion | 692.96 million | -2.82 billion | -50.87 million |
| Net Borrowings | N/A | -205.58 million | 4.6 billion | 2.14 billion | 281.24 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | 1.11 billion | -1.91 billion |
| Change to Operating Activities | N/A | N/A | N/A | 1.66 billion | N/A |
| Change in Cash | -2.79 billion | 3.28 billion | 3.97 billion | 1.38 billion | -1.05 billion |
| Total Cash from Operating Activities | N/A | 4.3 billion | -592.09 million | 3.09 billion | 909.73 million |
| Depreciation | N/A | N/A | N/A | 1.32 billion | -792.86 million |
| Other Cash Flow from Investing Activities | N/A | 352.09 million | 2.33 billion | -1.21 billion | 125.1 million |
| Change to Inventory | N/A | N/A | N/A | 63.14 million | -1.29 billion |
| Change to Account Receivables | N/A | N/A | N/A | -5.08 billion | 6.6 billion |
| Other Cash Flow from Financing Activities | N/A | 519.95 million | -356.65 million | -740.03 million | -571.26 million |
| Change to Net Income | N/A | 2.56 billion | -1.63 billion | 1.12 billion | -967.57 million |
| Capital Expenditures | 519.36 million | 971.63 million | 742.01 million | 1.07 billion | 801.05 million |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 95.44 billion | N/A | N/A | 87.64 billion | 86.88 billion |
| Total Stockholder Equity | 44.36 billion | N/A | N/A | 41.66 billion | 40.93 billion |
| Other Current Liabilities | 5.95 billion | N/A | N/A | 12.32 billion | 13.45 billion |
| Total Assets | 148.9 billion | N/A | N/A | 137.03 billion | 135.65 billion |
| Common Stock | N/A | 2.84 billion | 2.84 billion | 2.84 billion | 2.84 billion |
| Other Current Assets | 1.24 billion | N/A | N/A | 3.06 billion | 3.79 billion |
| Retained Earnings | 24.33 billion | 24.83 billion | 24.68 billion | 23.64 billion | 22.99 billion |
| Other Liabilities | N/A | 3.27 billion | 2.68 billion | 2.74 billion | 1.9 billion |
| Other Assets | N/A | 4.23 billion | 3.86 billion | 5.65 billion | 2.95 billion |
| Cash | 22.22 billion | N/A | N/A | 18.15 billion | 17.23 billion |
| Total Current Liabilities | 81.43 billion | N/A | N/A | 74.61 billion | 74.59 billion |
| Other Stockholder Equity | N/A | -624.46 million | 15.1 billion | -542.23 million | 15.09 billion |
| Property, Plant & Equipment | N/A | 13.66 billion | 13.21 billion | 13.13 billion | 12.55 billion |
| Total Current Assets | 108.05 billion | N/A | N/A | 98.09 billion | 99.09 billion |
| Long Term Investments | N/A | N/A | N/A | 5.43 billion | 5.67 billion |
| Net Tangible Assets | N/A | 26.8 billion | 27.13 billion | 26.94 billion | 25.54 billion |
| Short Term Investments | 200 million | N/A | N/A | N/A | N/A |
| Long Term Debt | 9.87 billion | N/A | N/A | 9.13 billion | 9.45 billion |
| Inventory | 23.63 billion | N/A | N/A | 24.88 billion | 24.23 billion |
| Accounts Payable | 40.13 billion | N/A | N/A | 36.87 billion | 39.53 billion |
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Chart:
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) News:
Below you will find a list of latest news for Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2013-02-21 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1570300/000101915513000083/0001019155-13-000083-index.htm |
| 2016-02-01 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1570300/000119380516002371/0001193805-16-002371-index.htm |
| 2017-03-06 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1570300/000119380517000385/0001193805-17-000385-index.htm |
| 2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1570300/000119380519001695/0001193805-19-001695-index.htm |